Alder BioPharma (ALDR) Misses Q4 EPS by 7c

Alder BioPharma (NASDAQ: ALDR) reported Q4 EPS of ($0.97), $0.07 worse than the analyst estimate of ($0.90).

For earnings history and earnings-related data on Alder BioPharma (ALDR) click here.

You May Also Be Interested In

• Tesla plans 'flying' Roadster stunt at SpaceX Texas site as early as August
• SVB & T Corporation (SVBT) Tops Q2 EPS by 275c
• Star Equity Holdings (STRR) Misses Q2 EPS by 8c